Stuart Poulton
Evp, Chief Development Officer at Karyopharm Therapeutics Inc. (KPTI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $56K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 30SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 18994,632 held (−0%) | $7.10 | $1K | -94.5% |
| May 15SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 40394,821 held (−0%) | $9.50 | $4K | -95.9% |
| Mar 3SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 5,10194,328 held (−5%) | $9.41 | $48K | -95.9% |
| Feb 19SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 37899,429 held (−0%) | $8.63 | $3K | -95.5% |